• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT CA 19-9XR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT CA 19-9XR Back to Search Results
Catalog Number 02K91-38
Device Problem High Test Results (2457)
Patient Problem Test Result (2695)
Event Date 10/12/2018
Event Type  Injury  
Manufacturer Narrative
This report is being filed on an international product, architect ca19-9, list 02k91-38 that has a similar product distributed in the us, list 02k91-29 and 02k91-33, which is manufactured in (b)(4) usa.
 
Event Description
The account generated a false elevated patient result when using.Architect ca19-9xr.Initial result >1200 u/ml.Repeat result >1200 u/ml and 2445 u/ml (after dilution of instrument).The customer also tested using a beckman platform and the result was 18 u/ml.Architect quality controls and calibrations were normal.As a result of the false elevated results, the patient underwent an ultrasound and gastroscopy, with no abnormalities found.
 
Manufacturer Narrative
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of field data, and a review of labeling.No adverse trend was identified for the customer's issue.No return patient sample was available.Historical performance of the reagent lot was evaluated using world wide data.The patient data was analyzed and within established control limits.Labeling was reviewed and found to be adequate (intended use section of the architect ca 19-9xr reagent package insert which states that the architect ca 19-9xr assay is to be used as an aid in the management of pancreatic cancer patients in conjunction with other clinical methods).Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
 
Manufacturer Narrative
An error was identified on jan 16, 2019.This report was filed against the incorrect manufacturing site.Manufacturer report 3002809144-2019-00020 has been submitted to correct this, and all follow up information will be provided in that report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT CA 19-9XR
Type of Device
CA 19-9
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key8035013
MDR Text Key126015111
Report Number1415939-2018-00156
Device Sequence Number1
Product Code NIG
Combination Product (y/n)N
PMA/PMN Number
K052000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 01/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/02/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/16/2019
Device Catalogue Number02K91-38
Device Lot Number87015M800
Was Device Available for Evaluation? Yes
Date Manufacturer Received01/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-02; ARCHITECT I2000SR, LIST 03M74-02; ARCHITECT I2000SR, LIST 03M74-02; SERIAL (B)(4); SERIAL (B)(4); SERIAL (B)(4); ARCHITECT I2000SR, LIST 03M74-02; SERIAL (B)(4)
Patient Outcome(s) Other;
Patient Age49 YR
-
-